Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROSUVASTATIN Cause Disturbance in attention? 154 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 154 reports of Disturbance in attention have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.4% of all adverse event reports for ROSUVASTATIN.

154
Reports of Disturbance in attention with ROSUVASTATIN
0.4%
of all ROSUVASTATIN reports
0
Deaths
9
Hospitalizations

How Dangerous Is Disturbance in attention From ROSUVASTATIN?

Of the 154 reports, 9 (5.8%) required hospitalization, and 15 (9.7%) were considered life-threatening.

Is Disturbance in attention Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 154 reports have been filed with the FAERS database.

What Other Side Effects Does ROSUVASTATIN Cause?

Myalgia (3,958) Dyspnoea (2,832) Pain (2,758) Drug ineffective (2,347) Fatigue (2,208) Rhabdomyolysis (2,173) Arthralgia (1,879) Asthma (1,843) Muscle spasms (1,843) Pain in extremity (1,686)

What Other Drugs Cause Disturbance in attention?

LEVOTHYROXINE (1,718) METHYLPHENIDATE (1,414) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (1,321) DULOXETINE (986) PREGABALIN (950) LISDEXAMFETAMINE DIMESYLATE (911) OXYCODONE (829) QUETIAPINE (747) ACETAMINOPHEN\HYDROCODONE (746) ACETAMINOPHEN\OXYCODONE (734)

Which ROSUVASTATIN Alternatives Have Lower Disturbance in attention Risk?

ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN ROSUVASTATIN vs ROTIGOTINE ROSUVASTATIN vs ROXADUSTAT ROSUVASTATIN vs ROXICODONE ROSUVASTATIN vs ROXITHROMYCIN

Related Pages

ROSUVASTATIN Full Profile All Disturbance in attention Reports All Drugs Causing Disturbance in attention ROSUVASTATIN Demographics